UniQure, Syndax, Erasca Drawing Fresh Analyst Interest
Three clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Determine which IRA is best for low-cost index funds to minimize fees and maximize long-term growth across portfolios.
27,103 articlesThree clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Geopolitics and energy markets collide as Iran-related headlines drive price moves. Investors are reassessing risk, h...
KB Home lands its first land deal in the Atlanta area, purchasing 110 homesites for the Whitley Meadows community and...
As markets shift, investors wonder if the Vanguard Total International Stock ETF is a smarter pick today than a month...
Investors greeted a policy-driven pact between Apple and Intel, sending intel shares leap after the announcement and ...
Bitcoin’s price finally entered a defined buy zone this week, signaling a potential shift in sentiment as traders wei...
As 2026 retirement limits rise, owner-operators may qualify for a far larger Solo 401(k) than company drivers using a...
A year after federal funding ended, South Dakota's public media network stays on air thanks to local support, partner...
Rolex opens a tuition-free watchmaking training center in Dallas to tackle a shrinking U.S. talent pool, drawing hund...
Analysts say ethereum price predictions analyst signals point to a potential rebound as ETH tests a key support, with...
Rivian's R2 carries big expectations at a $60,000 price tag. This piece breaks down what that price means for demand,...
A new study shows a $1.1 million dividend portfolio yielding 7% can generate roughly $77,000 per year, surpassing med...